Go Pro
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel Free NOG Stock Alerts

Nostrum Oil & Gas (NOG) Competitors

Nostrum Oil & Gas logo
GBX 3.20 +0.03 (+0.79%)
As of 12:27 PM Eastern
Compare

NOG vs. EOG, BRY, MXC, HNR, and SUN

Should you buy Nostrum Oil & Gas stock or one of its competitors? MarketBeat compares Nostrum Oil & Gas with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Nostrum Oil & Gas include Europa Oil & Gas (EOG), Brady (BRY), Argent BioPharma (MXC), Highlands Natural Resources (HNR), and Surgical Innovations Group (SUN). These companies are all part of the "petroleum and natural gas" industry.

How does Nostrum Oil & Gas compare to Europa Oil & Gas?

Europa Oil & Gas (LON:EOG) and Nostrum Oil & Gas (LON:NOG) are both small-cap energy companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, profitability, risk, analyst recommendations, dividends and institutional ownership.

0.8% of Europa Oil & Gas shares are held by institutional investors. Comparatively, 9.7% of Nostrum Oil & Gas shares are held by institutional investors. 13.6% of Europa Oil & Gas shares are held by company insiders. Comparatively, 44.0% of Nostrum Oil & Gas shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Europa Oil & Gas has a net margin of -70.04% compared to Nostrum Oil & Gas' net margin of -184.95%. Nostrum Oil & Gas' return on equity of 88.74% beat Europa Oil & Gas' return on equity.

Company Net Margins Return on Equity Return on Assets
Europa Oil & Gas-70.04% -78.82% 3.90%
Nostrum Oil & Gas -184.95%88.74%1.53%

Europa Oil & Gas has higher earnings, but lower revenue than Nostrum Oil & Gas. Europa Oil & Gas is trading at a lower price-to-earnings ratio than Nostrum Oil & Gas, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Europa Oil & Gas£3.57M6.75-£6.78M-£0.71N/A
Nostrum Oil & Gas£120.77M0.04-£121.71M-£134.00N/A

In the previous week, Europa Oil & Gas had 1 more articles in the media than Nostrum Oil & Gas. MarketBeat recorded 1 mentions for Europa Oil & Gas and 0 mentions for Nostrum Oil & Gas. Nostrum Oil & Gas' average media sentiment score of 0.00 beat Europa Oil & Gas' score of -0.38 indicating that Nostrum Oil & Gas is being referred to more favorably in the news media.

Company Overall Sentiment
Europa Oil & Gas Neutral
Nostrum Oil & Gas Neutral

Nostrum Oil & Gas has a consensus price target of GBX 4, indicating a potential upside of 24.80%. Given Nostrum Oil & Gas' stronger consensus rating and higher probable upside, analysts clearly believe Nostrum Oil & Gas is more favorable than Europa Oil & Gas.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Europa Oil & Gas
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Nostrum Oil & Gas
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Europa Oil & Gas has a beta of 0.039, indicating that its share price is 96% less volatile than the broader market. Comparatively, Nostrum Oil & Gas has a beta of 0.751, indicating that its share price is 25% less volatile than the broader market.

Summary

Nostrum Oil & Gas beats Europa Oil & Gas on 9 of the 15 factors compared between the two stocks.

How does Nostrum Oil & Gas compare to Brady?

Nostrum Oil & Gas (LON:NOG) and Brady (LON:BRY) are both small-cap petroleum and natural gas companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, risk, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends.

Nostrum Oil & Gas currently has a consensus target price of GBX 4, suggesting a potential upside of 24.80%. Given Nostrum Oil & Gas' stronger consensus rating and higher probable upside, research analysts plainly believe Nostrum Oil & Gas is more favorable than Brady.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nostrum Oil & Gas
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Brady
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Nostrum Oil & Gas' average media sentiment score of 0.00 equaled Brady'saverage media sentiment score.

Company Overall Sentiment
Nostrum Oil & Gas Neutral
Brady Neutral

Brady has lower revenue, but higher earnings than Nostrum Oil & Gas. Nostrum Oil & Gas is trading at a lower price-to-earnings ratio than Brady, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nostrum Oil & Gas£120.77M0.04-£121.71M-£134.00N/A
Brady£22.16M0.00N/A-£3.70N/A

9.7% of Nostrum Oil & Gas shares are owned by institutional investors. 44.0% of Nostrum Oil & Gas shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Brady has a net margin of 0.00% compared to Nostrum Oil & Gas' net margin of -184.95%. Nostrum Oil & Gas' return on equity of 88.74% beat Brady's return on equity.

Company Net Margins Return on Equity Return on Assets
Nostrum Oil & Gas-184.95% 88.74% 1.53%
Brady N/A N/A N/A

Summary

Nostrum Oil & Gas beats Brady on 8 of the 10 factors compared between the two stocks.

How does Nostrum Oil & Gas compare to Argent BioPharma?

Nostrum Oil & Gas (LON:NOG) and Argent BioPharma (LON:MXC) are both small-cap petroleum and natural gas companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, profitability, valuation, institutional ownership, analyst recommendations, earnings, risk and dividends.

Nostrum Oil & Gas has a beta of 0.751, indicating that its share price is 25% less volatile than the broader market. Comparatively, Argent BioPharma has a beta of 1.03, indicating that its share price is 3% more volatile than the broader market.

In the previous week, Argent BioPharma's average media sentiment score of 2.00 beat Nostrum Oil & Gas' score of 0.00 indicating that Argent BioPharma is being referred to more favorably in the news media.

Company Overall Sentiment
Nostrum Oil & Gas Neutral
Argent BioPharma Very Positive

9.7% of Nostrum Oil & Gas shares are owned by institutional investors. Comparatively, 1.2% of Argent BioPharma shares are owned by institutional investors. 44.0% of Nostrum Oil & Gas shares are owned by insiders. Comparatively, 8.2% of Argent BioPharma shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Argent BioPharma has a net margin of 0.00% compared to Nostrum Oil & Gas' net margin of -184.95%. Nostrum Oil & Gas' return on equity of 88.74% beat Argent BioPharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Nostrum Oil & Gas-184.95% 88.74% 1.53%
Argent BioPharma N/A N/A -58.96%

Nostrum Oil & Gas currently has a consensus price target of GBX 4, suggesting a potential upside of 24.80%. Given Nostrum Oil & Gas' stronger consensus rating and higher possible upside, research analysts clearly believe Nostrum Oil & Gas is more favorable than Argent BioPharma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nostrum Oil & Gas
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Argent BioPharma
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Argent BioPharma has lower revenue, but higher earnings than Nostrum Oil & Gas. Nostrum Oil & Gas is trading at a lower price-to-earnings ratio than Argent BioPharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nostrum Oil & Gas£120.77M0.04-£121.71M-£134.00N/A
Argent BioPharma£1.32M0.00-£17.02M-£1.66N/A

Summary

Nostrum Oil & Gas beats Argent BioPharma on 8 of the 13 factors compared between the two stocks.

How does Nostrum Oil & Gas compare to Highlands Natural Resources?

Nostrum Oil & Gas (LON:NOG) and Highlands Natural Resources (LON:HNR) are both small-cap energy companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, earnings, dividends, risk, valuation and media sentiment.

Nostrum Oil & Gas currently has a consensus target price of GBX 4, suggesting a potential upside of 24.80%. Given Nostrum Oil & Gas' stronger consensus rating and higher probable upside, equities research analysts plainly believe Nostrum Oil & Gas is more favorable than Highlands Natural Resources.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nostrum Oil & Gas
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Highlands Natural Resources
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Nostrum Oil & Gas' average media sentiment score of 0.00 equaled Highlands Natural Resources'average media sentiment score.

Company Overall Sentiment
Nostrum Oil & Gas Neutral
Highlands Natural Resources Neutral

Highlands Natural Resources has lower revenue, but higher earnings than Nostrum Oil & Gas. Nostrum Oil & Gas is trading at a lower price-to-earnings ratio than Highlands Natural Resources, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nostrum Oil & Gas£120.77M0.04-£121.71M-£134.00N/A
Highlands Natural Resources£1.02M0.00N/A-£4.90N/A

Highlands Natural Resources has a net margin of 0.00% compared to Nostrum Oil & Gas' net margin of -184.95%. Nostrum Oil & Gas' return on equity of 88.74% beat Highlands Natural Resources' return on equity.

Company Net Margins Return on Equity Return on Assets
Nostrum Oil & Gas-184.95% 88.74% 1.53%
Highlands Natural Resources N/A N/A N/A

9.7% of Nostrum Oil & Gas shares are owned by institutional investors. 44.0% of Nostrum Oil & Gas shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Nostrum Oil & Gas beats Highlands Natural Resources on 8 of the 10 factors compared between the two stocks.

How does Nostrum Oil & Gas compare to Surgical Innovations Group?

Surgical Innovations Group (LON:SUN) and Nostrum Oil & Gas (LON:NOG) are both small-cap petroleum and natural gas companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.

2.8% of Surgical Innovations Group shares are owned by institutional investors. Comparatively, 9.7% of Nostrum Oil & Gas shares are owned by institutional investors. 22.2% of Surgical Innovations Group shares are owned by insiders. Comparatively, 44.0% of Nostrum Oil & Gas shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Surgical Innovations Group has a net margin of -4.96% compared to Nostrum Oil & Gas' net margin of -184.95%. Nostrum Oil & Gas' return on equity of 88.74% beat Surgical Innovations Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Surgical Innovations Group-4.96% -6.04% -3.03%
Nostrum Oil & Gas -184.95%88.74%1.53%

Nostrum Oil & Gas has a consensus target price of GBX 4, indicating a potential upside of 24.80%. Given Nostrum Oil & Gas' stronger consensus rating and higher probable upside, analysts clearly believe Nostrum Oil & Gas is more favorable than Surgical Innovations Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Surgical Innovations Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Nostrum Oil & Gas
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Surgical Innovations Group has a beta of 0.65, indicating that its stock price is 35% less volatile than the broader market. Comparatively, Nostrum Oil & Gas has a beta of 0.751, indicating that its stock price is 25% less volatile than the broader market.

Surgical Innovations Group has higher earnings, but lower revenue than Nostrum Oil & Gas. Surgical Innovations Group is trading at a lower price-to-earnings ratio than Nostrum Oil & Gas, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgical Innovations Group£11.60M0.36N/A-£0.10N/A
Nostrum Oil & Gas£120.77M0.04-£121.71M-£134.00N/A

In the previous week, Surgical Innovations Group had 1 more articles in the media than Nostrum Oil & Gas. MarketBeat recorded 1 mentions for Surgical Innovations Group and 0 mentions for Nostrum Oil & Gas. Surgical Innovations Group's average media sentiment score of 0.67 beat Nostrum Oil & Gas' score of 0.00 indicating that Surgical Innovations Group is being referred to more favorably in the media.

Company Overall Sentiment
Surgical Innovations Group Positive
Nostrum Oil & Gas Neutral

Summary

Nostrum Oil & Gas beats Surgical Innovations Group on 9 of the 14 factors compared between the two stocks.

Get Nostrum Oil & Gas News Delivered to You Automatically

Sign up to receive the latest news and ratings for NOG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NOG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NOG vs. The Competition

Export
MetricNostrum Oil & GasOil & Gas E&P IndustryEnergy SectorLON Exchange
Market Cap£5.29M£1.85B£9.76B£2.84B
Dividend Yield5.36%7.70%10.72%6.17%
P/E Ratio-0.0228.6919.05368.18
Price / Sales0.042,095.23624.8684,612.72
Price / Cash0.0285.5336.8327.87
Price / Book-0.042.324.137.49
Net Income-£121.71M£82.07M£4.24B£5.89B
7 Day Performance0.12%2.59%2.03%-0.48%
1 Month Performance6.83%-4.75%-4.52%-1.00%
1 Year Performance6.13%34.38%28.40%61.74%

Nostrum Oil & Gas Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NOG
Nostrum Oil & Gas
1.2784 of 5 stars		GBX 3.21
+0.8%		GBX 4
+24.8%		+5.3%£5.29M£120.77MN/A30
EOG
Europa Oil & Gas
N/AGBX 1.70
-5.6%		N/A+248.5%£22.37M£3.57MN/A2,850
BRY
Brady
N/AN/AN/AN/A£15.17M£22.16MN/A1,370
MXC
Argent BioPharma
N/AN/AN/AN/A£9.65M£1.32MN/A5
HNR
Highlands Natural Resources
N/AN/AN/AN/A£6.95M£1.02MN/A16

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:NOG) was last updated on 7/13/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel